Please assess the completion status of the following clinical trial:

Trial Title: Organ Protection With Sevoflurane Postconditioning After Cardiac Surgery With Cardiopulmonary Bypass

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* CABG and/or heart valve surgery with CPB~* Ejection fraction (EF) = 30%~* Canadian Cardiovascular Society (CCS) classification = 3~* Ages 18 to 90 years old~Exclusion criteria:~* Pulmonary disease: forced expiratory volume in one second (FEV1) \< 80%; FEV1/forced vital capacity (FVC) \< 70%~* Renal disease and/ or creatinine-clearance \< 60 ml/min~* Previous cardiac surgery~* Emergency procedures~* Postoperative intra aortic balloon pump (IABP) requirement~* Myocardial infarction \< 7d~* Steroid treatment~* Insulin-dependent diabetes~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Sevoflurane (Type: EXPERIMENTAL): None
- Propofol (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).